CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-15). The draft was written by AI, the existence of all 1 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.7.
Verdict No. 2649 · Search date 2026-08-15 · Methodology v0.7

i-gel-first airway,
does it really help with Better functional recovery at discharge or 30 days than with a tracheal-intubation-first strategy?

30-Second Summary
D
Evidence Grade D · 34 · Safety caution
Initial ventilation improved, but 30-day functional recovery did not
Both i-gel and tracheal intubation are professional emergency airway procedures with risks including regurgitation, aspiration, airway trauma, failed placement, and delayed ventilation. They require trained responders working under protocol.
What the
research shows
The grade is D with 34 points. AIRWAYS-2 enrolled 9,296 patients and obtained the primary functional outcome for 9,289. Good functional recovery occurred in 311/4,882 (6.4%) with i-gel versus 300/4,407 (6.8%) with tracheal intubation, adjusted difference -0.6 percentage points (95% CI -1.6 to 0.4). Initial ventilation succeeded more often as a secondary outcome, but the primary functional outcome did not improve.
What the
ads claim
Ease of insertion and first-ventilation success should not be converted into better 30-day functional recovery. Airway choice depends on system proficiency, patient circumstances, and a rescue strategy after failure.
*

Useful facts when choosing a product

  • i-gel is a second-generation supraglottic airway with a soft noninflatable cuff.
  • AIRWAYS-2 compared i-gel-first with direct-laryngoscopy tracheal-intubation-first strategies.
  • Initial ventilation success was 87.4% versus 79.0%, while primary functional recovery was 6.4% versus 6.8%.
Gap Measurement · Verdict 2649 · D 34
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

AIRWAYS-2 stated allocation concealment as: “Paramedics were randomized in a 1:1 ratio using a purpose-designed secure internet-based system.” Assessor masking was stated as: “Patients were transported to and followed up at each hospital by assessors blinded to treatment group who collected the modified Rankin Scale score.” The analysis population was: “The primary analyses included all eligible patients with outcome data available.” mRS data were available for 9,289 of 9,296 patients, who were analyzed as assigned. The registration specified the primary endpoint as modified Rankin Scale “at hospital discharge,” whereas the paper reported it “at hospital discharge or 30 days,” so the time points do not match. NIHR HTA provided public funding.

02

Why this is classified as D (34)

A large publicly funded hard-outcome trial had a null prespecified primary functional outcome and no independent replication, giving D with 34 points.

Counterpoint. The confidence interval retained a small possible benefit, so the trial does not prove harm or exclude every benefit.

Rejudgment record. Evidence aligned — The registration specified the primary endpoint at hospital discharge, while the paper reported hospital discharge or 30 days

Scoring profile behind this grade
EndpointHHard endpoint - actual events such as death
ReplicationR1Single confirmatory trial
IndependenceI2Decisive evidence is publicly or non-profit funded
Effect sizeE0Null
PrecisionC0The confidence interval leaves room for benefit

The scoring table and the verdict agree (D).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
More good functional recovery at discharge or 30 daysDThe outcome did not improve, 6.4% versus 6.8%.
Higher initial ventilation successBThe secondary outcome was 87.4% versus 79.0%.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Benger JR, Kirby K, Black S, Brett SJ, Clout M, Lazaroo MJ, Nolan JP, Reeves BC, Robinson M, Scott LJ, Smartt H, South A, Stokes EA, Taylor J, Thomas M, Voss S, Wordsworth S, Rogers CA. 2018 AIRWAYS-2Pragmatic paramedic-cluster randomized trial with automatic patient enrollment and blinded functional-outcome assessors4,407Public NIHR Health Technology Assessment funding, project 12/167/102Modified Rankin Scale 0 to 3 at discharge or 30 days311/4,882 (6.4%) versus 300/4,407 (6.8%), adjusted difference -0.6 points (95% CI -1.6 to 0.4)Large publicly funded prespecified primary hard-outcome trial
§

Receipt — 1 References

All 1 cited sources were verified for existence at the original page (as of 2026-08-15).

Benger JR, Kirby K, Black S, Brett SJ, Clout M, Lazaroo MJ, Nolan JP, Reeves BC, Robinson M, Scott LJ, Smartt H, South A, Stokes EA, Taylor J, Thomas M, Voss S, Wordsworth S, Rogers CA. Effect of a Strategy of a Supraglottic Airway Device vs Tracheal Intubation During Out-of-Hospital Cardiac Arrest on Functional Outcome: The AIRWAYS-2 Randomized Clinical Trial. JAMA. 2018;320(8):779-791. PMID: 30167701. DOI: 10.1001/jama.2018.11597. ISRCTN08256118.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-15 · Corrections: none

Cite this verdict

i-gel-first airway x functional recovery after out-of-hospital cardiac arrest Evidence Grade D card
[Chamgap] i-gel-first airway x functional recovery after out-of-hospital cardiac arrest — Evidence Grade D·34. 1 cited sources checked. Source: https://chamgap.com/en/verdicts/general/i-gel-first-out-of-hospital-cardiac-arrest-functional-outcome/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.